The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass Pharma both headed to the Nasdaq this ...

RSP ETF is a compelling Strong Buy to capture the rotation from growth to dividend/value stocks in 2026. Click here to find ...

Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the 10 best NASDAQ growth stocks to buy for the next 10 years. Andrea Tan, an analyst at Goldman Sachs, raised the firm’s price target on Krystal Biotech, ...

It's obvious that the company has a good shot at returning to growth.

Biotech stock Pharming was pummeled Monday after the FDA rejected the company's request to expand the patient pool for Joenja ...

There's a growth stock that has skyrocketed more than Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) and Nvidia ...

Revvity, Inc. is rated a Hold due to stretched valuation, ongoing weakness in China diagnostics and NIH funding. Read more on ...

Investing.com - Evotec SE shares rose 8% after Berenberg initiated coverage of the German biotechnology company with a buy rating, saying the stock does not reflect the value of its long-term ...

Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector ...

While Moderna has outpaced the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook about the stock’s ...